Open and Recruiting Clinical Trials
COVID-19 CLINICAL TRIAL: ACTIV-2
Monoclonal Antibodies are one type of investigational medicine you might receive in the ACTIV-2 study. Antibodies are made by your body to help fight disease. When germs like viruses or bacterial enter your body, your immune system makes antibodies specific for that germ. These antibodies can help to destroy the germ or stop it from getting into your cells and making you sick. Monoclonal antibodies are made in the lab and are designed to attach to the coronavirus. They are injected into the skin or delivered by an infusion into a vein in the arm. Researchers want to see if, once inside the body, the monoclonal antibodies prevent the virus from entering and harming your cells.
Call 909-558-5830 to see if you are eligible for the trial or to refer a patient.
Please use the following links to find trials in the Specialties/Departments listed below.
Cancer-Related Clinical Trials
To search studies that are being conducted at Loma Linda University by using ClinicalTrials.gov's search engine click here.